Financials SoftOx Solutions

Equities

SOFTX

NO0010811961

Biotechnology & Medical Research

Market Closed - Oslo Bors 10:45:00 2024-04-26 am EDT 5-day change 1st Jan Change
0.218 NOK +2.83% Intraday chart for SoftOx Solutions -0.91% -93.27%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 100.3 237.2 611.7 564.7 241
Enterprise Value (EV) 1 99.08 161.2 576.9 507.7 234.1
P/E ratio -6.58 x -14.5 x -15.6 x -8.86 x -3.39 x
Yield - - - - -
Capitalization / Revenue 23.2 x 57.9 x 62.2 x 71.5 x 33.9 x
EV / Revenue 22.9 x 39.3 x 58.6 x 64.3 x 32.9 x
EV / EBITDA -6.13 x -7.99 x -11.9 x -6.17 x -2.69 x
EV / FCF -10.2 x -30.2 x -11.4 x -11.3 x -4.23 x
FCF Yield -9.81% -3.32% -8.77% -8.81% -23.7%
Price to Book 5.9 x 2.74 x 7.65 x 5.28 x 6.22 x
Nbr of stocks (in thousands) 4,459 7,751 8,739 10,083 10,343
Reference price 2 22.50 30.60 70.00 56.00 23.30
Announcement Date 5/31/19 6/18/20 4/6/21 5/4/22 6/14/23
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.001 4.323 4.099 9.839 7.901 7.114
EBITDA 1 -12.2 -16.17 -20.17 -48.66 -82.32 -87.15
EBIT 1 -13.17 -17.29 -21.87 -51.36 -86.1 -91.05
Operating Margin -1,316,857.8% -399.86% -533.55% -522.03% -1,089.71% -1,280.01%
Earnings before Tax (EBT) 1 -13.17 -17.46 -22.18 -49.71 -86.29 -93.7
Net income 1 -9.408 -12.93 -16.34 -37.41 -65.4 -71.14
Net margin -940,826.6% -299.06% -398.54% -380.17% -827.74% -1,000.07%
EPS 2 -3.781 -3.422 -2.108 -4.491 -6.324 -6.878
Free Cash Flow 1 -11.9 -9.725 -5.345 -50.62 -44.73 -55.4
FCF margin -1,190,367.6% -224.95% -130.4% -514.5% -566.16% -778.75%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/1/18 5/31/19 6/18/20 4/6/21 5/4/22 6/14/23
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 17.1 1.24 76 34.8 57 6.91
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -11.9 -9.72 -5.35 -50.6 -44.7 -55.4
ROE (net income / shareholders' equity) -64.2% -62.7% -32.4% -46% -70.3% -95.8%
ROA (Net income/ Total Assets) -41.3% -39.7% -21.3% -33.4% -50% -49.8%
Assets 1 22.8 32.57 76.7 112 130.9 142.9
Book Value Per Share 2 10.80 3.810 11.20 9.150 10.60 3.750
Cash Flow per Share 2 6.870 0.3300 9.800 4.180 5.510 0.6700
Capex 1 1.49 1.44 3.2 7.67 4.6 4.85
Capex / Sales 148,564.7% 33.4% 78.09% 77.94% 58.16% 68.24%
Announcement Date 6/1/18 5/31/19 6/18/20 4/6/21 5/4/22 6/14/23
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SOFTX Stock
  4. Financials SoftOx Solutions